Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Lucis is a Paris-based preventive health platform that combines blood biomarker testing, AI-assisted interpretation, and medically reviewed action plans to help people understand and improve their health proactively.
Primary product
Preventive health membership platform with biomarker testing, AI-driven insights, and personalized action plans.
Founded
2025
Headquarters
Paris, France
Team size
20-30
Work style
Hybrid
Industry
Health and Human Services
Sub-industry
Preventive health / healthtech
Offices
Business model
Stage
Series A
Total raised
$29M
Latest round
Series A · May 2026
Latest amount
$20M
May 2026 · Singular
Dec 2025 · General Catalyst
Jun 2025
Leadership
CEO & Co-founder
CTO & Co-founder
Chief Medical Officer
Head of Operations
Clinical & Product Lead
President, scientific board
Founders
Co-founder
Mission-driven and AI-native, with strong in-person collaboration from a Paris hub. The company emphasizes speed, autonomy, preventive health, and medically grounded execution.
Work style
Hybrid
Compensation
Publicly advertised compensation signals include competitive salaries and meaningful equity; no public salary bands were found.
Benefits
Pricing
Annual membership subscriptions, with Discovery at €190/year and Care at €490/year, plus optional add-on tests.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Low seven figures ARR (~$1.1M estimated; third-party estimates vary)
Estimated monthly visits
73.1K
Traffic estimate as of Jul 2026
Lucis · May 2026
Official Series A announcement. Lucis says the round was led by Singular with participation from General Catalyst, Y Combinator, and angels, bringing total funding to $28M on the company’s own count and describing the platform’s expansion plans across Europe.
Tech.eu · May 2026
Independent coverage of the Series A; reports Singular led the round and says the company had previously raised $8M, bringing total funding to $28M.
Tech.eu · Dec 2025
Reports Lucis closed an $8.5M seed round led by General Catalyst, with participation from Y Combinator, Kima Ventures, Motier Ventures, Circle.Co, and North South Ventures.
FinSMEs · Dec 2025
Another independent seed-round report confirming the $8.5M raise and the same investor group, plus details on Lucis’s preventive-health platform.
BeBeez International · Dec 2025
European coverage of the seed round, including the investor mix and Lucis’s Europe-wide preventive-health positioning.
0 jobs at Lucis
Check back later for new openings